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Human Th17 Cell Clones and Natural
Immune Responses
Sho Matsushita1 and Takehiro Higashi1
ABSTRACT
Immunomodulators such as lipopolysaccharides (LPS) and forskolin change the nature of dendritic cells (DCs)
to induce Th1 and Th2 cells, respectively, thereby designated Th1 or Th2 adjuvants. Recent studies showed
that Th17-inducing activity can be carried by certain polysaccharides such as β-glucan derived from Candia al-
bicans. Such activities can be scrutinized by using MLR, cAMP and possibly, differential expression of Notch
ligand isoforms. In this review article, we also introduce an effective method to establish human Th17 cell
clones and a transcriptome analysis using human Th subpopulations. In vivo relevance to human Th17 re-
sponses is discussed.
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INTRODUCTION
DCs are antigen-presenting cells (APCs) specialized
to activate naïve T lymphocytes and initiate primary
immune responses. The different classes of specific
immune responses are driven by the biased develop-
ment of antigen-specific effector CD4+ T-cell subsets
such as Th1, Th2 and Th17 cells, that activate differ-
ent components of cellular and humoral immunity.
The Th17 lineage characteristically produces high
levels of IL-17, and it has also been identified to repre-
sent a significant revision of the Th1―Th2 para-
digm.1,2 Moreover, Th17 cells have been reported to
play not only critical roles in the immune responses
to extracellular microorganisms such as fungi but
also a pathogenetic role in autoimmunity.1,3-6 In this
review, we will introduce some of the recent ad-
vances in this field, especially adjuvant activities to in-
duce each Th cell subsets in humans.
Th17 RESPONSES IN HUMANS
Murine naive CD4T+ cells activated in the presence
of TGFβ and IL-2 upregulate Foxp3 and develop into
‘inducible’ T regulatory cells (Treg cells), whereas
CD4+ T cells cultured with TGFβ and IL-6 express
the transcription factor RORγt and become Th17
cells, which protect against bacterial and fungal infec-
tion and contribute to autoimmunity.
Despite the critical function of TGFβ in the differ-
entiation of mouse Th17 cells, this cytokine is not
needed for IL-17 production in human T cells; in fact,
TGFβ rather inhibits IL-17 production.7 Additionally,
IL-1β is a very effective inducer of IL-17 protein ex-
pression in activated human CD4+ T cells, although
IL-1β only transiently induces RORγt. IL-6 alone is a
poor inducer of Th17 differentiation, but Sallusto and
colleagues found that the combination of IL-6 and IL-
1β promotes sustained RORγt expression and sub-
stantial numbers of cells producing both IL-17 and
IFNγ.7 They demonstrate that IL-23 alone is a rela-
tively ineffective inducer of IL-17, whereas de Waal
Malefyt and colleagues showed that IL-23 is a potent
inducer of Th17 cells.8 However, the amount of vari-
ation of IL-17 production by different donors is unex-
pectedly high.8 Sallusto and colleagues showed that
the combination of IL-1β and IL-23 generates more
IL-17 producers than does IL-1β alone, yet de Waal
Malefyt and colleagues showed that the combination
is not better than IL-1β alone.7,8 More importantly,
stimulation with these cytokines induces a mixed
population of cells producing IL-17 and IFNγ.7
Both teams agree that human Th17 cells produce
large amounts of IL-22, although mouse Th17 cells do
not uniquely produce this cytokine.7,8 IL-21 produc-
tion by human Th17 cells remains to be determined.
As noted above, it has been shown that this cytokine
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Fig. 1 Overview of the assay protocols for the establish
ment of human aloreactive Th17 clones.
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is selectively produced by mouse Th17 cells. If the
key function of IL-21 is an autocrine regulator of Th17
differentiation and its important effects on B cells, it
will be essential to examine the regulation of IL-21 in
human CD4+ T cells.
Sallusto et al. further showed that differentiation of
human Th17 cells is induced by activated APCs in the
absence of exogenous cytokines and cytokine anti-
bodies.7 They find that monocytes activated by Toll-
like receptor (TLR) ligands produce IL-6 and IL-1β
but small amounts of IL-12 and IL-23. Notably, activa-
tion of monocytes with peptideglycan (a ligand for
TLR2) provides a particularly effective stimulus for
Th17 differentiation, generating cells that selectively
produce IL-17.
Cells selectively producing IL-17 express the
chemokine receptors CCR6 and CCR4, whereas cells
producing both IL-17 and IFNγ express CCR6 and
CXCR3.6 This will be important in the trafficking of
the T cells generated. In this relation, Yamamura’s
group shows an interesting set of observation in this
review section.
de Waal Malefyt et al. point out that a substantial
proportion of memory CD4+ T cells express the IL-23
receptor (IL-23R) and, according to their data, these
IL-23R+ memory CD4 T cells are the main producers
of IL-17.8 However, once again, the data from human
donors show polymorphism in the secretion of this
cytokine.
In contrast to the results obtained with mice, de
Waal Malefy’s group showed that IL-2-activated cells
produce large amounts of IL-17, at least in some do-
nors.8 They conclude that this is another example of
species-specific regulation. However, Sallusto et al.
show that early on, IL-2 also inhibits the Th17 differ-
entiation of human CD4+ T cells.7 Moreover, they
also show that IL-2 will ultimately lead to the popula-
tion expansion of Th17 cells. These data are consis-
tent with another study showing that IL-17-producing
memory T cell populations are expanded by IL-2 in
both species.9
ESTABLISHMENT OF HUMAN ALLOREA-
TIVE Th17 CELL CLONES
Immature Mo-DCs were co-cultured with HLA-DR-
nonshared allogeneic CD4+ naïve T cells to induce
MLR. Alternatively, HLA-DR-nonshared PBMC of
two donors (2 × 103individual donorwell of micro-
culture plate, NUNC, Denmark) were co-cultured to
induce MLR. IL-1β, TNFα and IL-6 were added in
these MLR cultures. After an 8-day culture, the wells
where cells proliferated were typically 10% of all the
culture wells. As shown in Figure 1, the proliferating
wells were split into 2 wells of a 96-well flat-bottomed
culture plate, followed by feeding with irradiated (45
Gy) PBMC used for MLR (1 × 105well) plus IL-23.
After 6 days of culture, the supernatant fluids were
harvested to be subjected to IL-17, IL-5 and IFNγ de-
termination by ELISA. After an additional 24-h cul-
ture, typical Th1, Th2 and Th17 cells were cloned by
limiting dilution at 0.3―1.0 T cellswell in the pres-
ence of irradiated PBMC (manuscript in preparation).
DNA CHIP ANALYSIS
The total RNA was extracted from typical human
Th1, Th2 and Th17 cell clones. A gene expression
analysis was performed using Affymetrix GeneChipⓇ.
Briefly, 5 μg of total RNA was reverse transcribed and
second strand cDNA was obtained, then complemen-
tary RNA (cRNA) was synthesized by in vitro tran-
scription, incorporating biotin-labeled nucleotide.
Fragmented cRNA was hybridized on Affymetrix
GeneChipⓇ mouse Genome 430 2.0, and stained by
streptavidin phycoerythrin. After scanning, the quan-
tified data was analyzed by MAS5 normalization. We
could observe transcripts specific for each Th sub-
types, some of which are Th17-specific, which in-
cludes CCL20 and CCR6 (manuscript in preparation).
HUMAN Th17 RESPONSES TO Candida al-
bicans
Th17 responses could be observed by using human
PBMC stimulated with various exogenous antigens,
such as Candida albicans6 and purified protein deriva-
tive. This observation indicates that a certain differen-
Human Th17 Responses
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Fig. 2 Overview of the assay protocol for the determination of adjuvant activities.
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tiation pressure onto naïve CD4 T cells is carried by
each exogenous antigen as a crude form. Then, what
kind of substances are responsible for such a differ-
entiation pressure? Indeed, for Th1 and Th2 re-
sponses, specific adjuvant activities have been exten-
sively described, which is often associated with DCs.
The balance of these cytokines and the resulting
class of immune responses strongly depend on the
conditions under which the DCs are primed.10
The ligands for many isoforms of TLRs, including
certain nucleic acids, LPS and fungus-derived gly-
coprotein molecules, alter the DC function, and in-
duce Th1 differentiation in an antigen non-specific
manner.11 In this process, IL-12 produced by DCs is
clearly correlates with the sensitization of Th1.12 On
the other hand, DCs matured in the presence of
PGE2, histamine, or forskolin induce the differentia-
tion of naïve CD4+ T cells toward Th2 via a cAMP cas-
cade.13-15 However, contribution of the DC itself to Th
17 differentiation had been long unclear.
Recently, it was demonstrated that zymosan, one of
β-glucan, binds to dectin-1, and leads to the activation
of Syk followed by the production of IL-23 from APC
and IL-17 from T cells.16 Actually, zymosan carries a
component that is capable of stimulating TLR26.
Use of curdlan instead of zymosan can avoid such a
contaminating signal and thus suitable for investigat-
ing signal transduction mechanisms necessary for in-
ducing DC17, via a cascade distinct from TLR.16
Th1, Th2, Th17 ADJUVANTS AND THEIR
EVALUATION USING MLR
As shown in Figure 2, human CD14+ cells were iso-
lated from adult blood buffy coat specimens from
healthy volunteer blood donors. These cells were fur-
ther separated into CD45RO+ memory T cells and
CD45RA+ naïve T cells. The CD14+ cells were stimu-
lated with IL-4 and GM-CSF for 5 days, and then the
cells were harvested as immature Mo-DCs. After
washing, immature Mo-DCs were stimulated with the
various chemicals to be tested. Two days after the in-
cubation with chemicals, cellular components were
further co-cultured with HLA-DR-nonshared alloge-
neic CD4+ naïve T cells to induce an MLR for 8 days.
Thereafter, the T cells were restimulated with anti-
CD3 and anti-CD28 plate-bound Abs. Culture super-
natants were harvested after 16 hr to be assayed for
IFNγ, IL-5 and IL-17 by an ELISA.
Th1 AND Th2 ADJUVANTS AND THEIR
EVALUATION USING NOTCH LIGAND ISO-
FORMS
One of the alternative methods for this time-
consuming method is to evaluate Notch ligand iso-
forms expressed on APCs.17 Notch signaling path-
ways are highly conserved in organisms ranging
from invertebrates to mammals and they are involved
in cell fate choice during development.18 In mam-
mals, four Notch receptors, Notch1―4, and five Notch
ligands, Delta1, Delta3, Delta4, Jagged1, and Jag-
ged2, have so far been identified. Amsen et al. have
Matsushita S et al.
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Fig. 3 The Notch ligand gene expression profiles were 
evaluated in PMA-induced KG-1-derived DC-like cels at 6 
hrs after indicated stimulations.
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presented evidence that different Notch ligands ex-
pressed on antigen-presenting cells (APCs) instruct
Th1Th2 differentiation in mice.19 They found the
MyD88-dependent induction of Delta4 expression as
well as the MyD88-independent induction of Jagged1
expression by a Th1-promoting stimulus, i.e. Th1 ad-
juvant lipopolysaccharide (LPS) on mouse DCs. Like-
wise, the induction of the Jagged2 expression by a
Th 2-promoting stimulus, i. e. Th 2 adjuvant
prostaglandin E2 (PGE2) on mouse DCs was ob-
served. Because of the association of MyD88-
independent TLR signaling with Th2 response induc-
tion, it was concluded that the induced expression of
Jagged members correlated with the Th2 adjuvant ac-
tivities while the induced expression of Delta mem-
bers correlated with the Th1 adjuvant activities.19,20
In addition, APCs retrovirally transduced to express
Jagged1 promoted Th2 differentiation, while APCs
retrovirally transduced to express Delta1 promoted
Th1 differentiation.19 Consistent with their report,
Maekawa et al. reported the induction of mouse Th1
differentiation by Delta1-Notch3 interactions.21 How-
ever, other groups have provided observations which
conflict with the findings of these studies.22-26
Collectively, the Notch ligands expressed on APCs
potentially impact peripheral mature T cell differen-
tiation, but their nature still remains under investiga-
tion. Most previous studies have been based on
mouse experiments concentrating on the functional
relevance of Notch signaling within T cells, while the
information about Notch ligands expressed on APCs
has been provided by only a limited number of mouse
studies.19,22,27-30 To assess the issue, we examined
correlation of Notch ligand mRNA levels of human
APCs with Th1Th2-promoting stimulations, i.e.
Th1Th2 adjuvant activities. The expression patterns
of human DCs and leukemic cell line models of APCs
differed partly from those previously observed in
mouse DCs and by cellular types and maturation
stages. Most strikingly, Th2 adjuvants enhanced the
Delta1 expression on human APCs but did not induce
Delta4 expression, which was induced by a Th1 adju-
vant, as shown in Figure 3. The differential expres-
sion patterns suggest a distinct role of these Delta
members in Th1Th2 differentiation and their predic-
tive potential for Th1Th2-promoting activities. Notch
ligand expression of DC17 cells is currently under in-
vestigation.
Th1 AND Th2 ADJUVANTS AND THEIR
EVALUATION USING cAMP
As shown earlier, forskolin but not LPS induced in-
creased Delta1 mRNA expression on PMA-treated
THP-1 cells. Because LPS induced increased Delta4
expression in our previous study,17 such differential
induction of Notch ligand isoforms can be used for a
qualitative evaluation of Th1Th2 adjuvants. How-
ever, quantitative evaluation of the activities requires
real-time RT-PCR analysis, which is not suitable for a
high-throughput assay. We therefore tried to use in-
tracellular cAMP levels for the high-throughput assay
as shown in Figure 4, which have been reportedly in-
creased by Th2 adjuvants.31
Mock-treated THP-1 cells did not exhibit forskolin-
induced cAMP elevation. In PMA-treated THP-1 cells,
cAMP elevation was observed in a forskolin dose-
dependent manner. Such forskolin-induced cAMP
elevation in the presence of PMA can be used as tar-
get cells for Th2 adjuvants. Thus, as shown in Figure
5, PMA-treated and forskolin-induced cAMP eleva-
tion was inhibited by LPS, in a dose-dependent man-
ner. Thus, forskolin-induced cAMP elevation was suc-
cessfully antagonized by LPS, again in a dose-
dependent manner, which is indicative of the avail-
ability for the quantitative evaluation of the Th1 adju-
vant activity.
The detection of Th1Th2 adjuvant activities has
long been dependent on an assay for the cytokine
profiles induced on T cells by co-culturing with APCs
stimulated with adjuvants.32 This assay requires a
large amount of labor and more than 2 weeks due to
the preparation of cells from healthy donors and a
Human Th17 Responses
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Fig. 4 Overview of the assay protocols for determination 
of adjuvant activities using antigen presenting cels in vitro.
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large number of culture processes. In addition, the
heterogeneities of cell sources and donor-to-donor
variances may also lead to difficulties in obtaining sta-
ble and reproducible results. The measurement of in-
tracellular cAMP in PMA-derived THP-1 cells have
potential to scrutinize and evaluate Th1Th2 adjuvant
candidates out of a large number of environmental
substances and natural products, without possible in-
stability arising from cell sources and polymor-
phisms. It is also of note that this assay system can be
used for the evaluation of live bacteria, because 3-hr
incubation with live probiotic bacteria did not de-
crease the viability of THP-1 cells and successfully in-
duced Delta1 and Delta4.17
In vivo RELEVANCE TO HUMAN Th17 RE-
SPONSES
RA
IL-17 or Th17 cells were reportedly correlated with
autoimmune inflammatory diseases in humans from
several studies. Kotake et al. demonstrated that levels
of IL-17 in synovial fluids were significantly higher in
RA patients than OA patients and that IL-17 played
important role in osteoclastic bone resorption.33
Chabaud et al. reported that a subset of infiltrating T
cells expressed IL-17 in RA synovium.34
MS
Th17 plays a critical role in EAE. Data that link Th17
to multiple sclerosis in humans is also emerging. Sev-
eral studies demonstrated that MS patients had a sig-
nificant number of IL-17 mRNA-positive MNCs from
peripheral blood or cerebrospinal fluid.35,36 Lock et al.
reported that microarray analysis of MS plapues iso-
lated at autopsy exhibited 18-fold increase in IL-17
mRNA compared with the amount found in brains
from control patients that did not have nervous sys-
tem pathology.37 Moreover, isolated CD4+ T cells
from MS patients stimulated in vitro using anti-CD3
produced significantly more IL-17 compared with T
cells from healthy donors.35
IBD
Fujino et al. demonstrated that IL-17 expression was
observed in CD3+ T cells in the inflamed mucosa of
active Crohn’s disease (CD) and ulcerative colitis
(UC).38 They also reported the number of IL-17-
positive cells per field in active CD and serum levels
of IL-17 in both CD and UC, were significantly higher
than in patients who had inactive disease.
PSORIASIS
Wilson et al. demonstrated IL-17A and IL-17F mRNA
had significantly higher expression in psoriatic skin
lesion than in nonlesional or healthy skin.8 Further-
more, RORC mRNA which is the gene encoding
RORγt was also upregulated in the psoriatic lesion.
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